On September 12, Allergan (AGN) announced the launch of Spotlyte, the first launch from Project Moonwalker, the Allergan-owned digital ventures unit. Spotlyte is an innovative digital hub designed to educate consumers about medical aesthetic treatments. The below chart lists key updates on Spotlyte.
Spotlyte is the first venture from Project Moonwalker and is designed to educate consumers about medical aesthetics. According to the press release, there are over 65 million consumers in America who consider a variety of medical aesthetics treatments including facial injectables, breast implants, and body contouring. Nearly 30% of these consumers feel that the lack of information is a top barrier in regards to medical aesthetics treatments.
The site is designed with the goal of providing well-researched and accurate information to educate consumers about medical aesthetic procedures. The site is brand agnostic and aims to provide unbiased information. The site also has an on-site chat feature that connects consumers with specialists and helps with details about local licensed providers.
The CEO of Allergan, Brent Saunders, commented that Allergan has the responsibility and opportunity to educate consumers about medical aesthetics, as Allergan is a market leader. He also added that the medical aesthetics market could double over the next five to seven years.